Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists

Molecular Human Reproduction

Volumn 20, Issue 5, 2014, Pages 433-441

  Corcoran, Jemma J ^a   Nicholson, Christopher ^b   Sweeney, Michèle ^b   Charnock, Jayne C ^a   Robson, Stephen C ^b   Westwood, Melissa ^a   Taggart, Michael J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

ER agonists; Estrogen; Human placental arteries; Human uterine arteries; Vascular tone

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; ESTROGEN RECEPTOR ALPHA, HUMAN; MESSENGER RNA; NITRIC OXIDE; VASODILATOR AGENT;

ARTERY TONE; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PLACENTA CIRCULATION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE ARTERY; UTERUS BLOOD FLOW; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; PLACENTA; VASCULARIZATION; VASODILATATION;

CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; NITRIC OXIDE; PLACENTA; PREGNANCY; RNA, MESSENGER; UTERINE ARTERY; VASODILATION; VASODILATOR AGENTS;

EID: 84899829524     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gat095     Document Type: Article

References (35)

1. Al Zubair K, Razak A, Bexis S, Docherty JR. Relaxations to oestrogen receptor subtype selective agonists in rat and mouse arteries. Eur J Pharmacol 2005;513:101-108.
2. Bolego C, Cignarella A, Sanvito P, Pelosi V, Pellegatta F, Puglisis L, Pinna C. The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-α agonists and is abolished by estrogen deprivation. J Pharmacol Exp Ther 2005;313:1203-1208.
3. Byers MJ, Zangl A, Phernetton TM, Lopez G, Chen D-b, Magness RR. Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERα and ERβ levels. J Physiol 2005;565:85-99.
4. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004;145:113-125.
5. Corcoran JJ, Charnock JC, Martin J, Taggart MJ, Westwood M. Differential effect of insulin like growth factor-I on constriction of human uterine and placental arteries. J Clin Endocrinol Metab 2012;97:e2098-e2104.
6. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, SLayden OD, Millar MR, Saunders PT. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001;86:1370-1378.
7. Cruz MN, Agewall S, Schenck-Gustafsson K, Kublickiene K. Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. Atherosclerosis 2008; 196:49-58.
8. Dordea AC, Sweeney M, Taggart J, Lartey J, Wessel H, Robson SC, Taggart MJ. Differential vasodilation of human placental and myometrial arteries related to myofilament Ca2+-desensitization and the expression of Hsp20 but not MYPT1. Mol Hum Reprod 2013;19: 727-736.
9. Feldman RD, Gros R. Unravelling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br J Pharmacol 2011;163:1163-1169.
10. Hass E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailou GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009;104:288-291.
11. Hayward CE, Higgins L, Cowley EJ, Greenwood SL, Mills TA, Sibley CP, Wareing M. Chorionic plate arterial function is altered in maternal obesity. Placenta 2013;34:281-287.
12. Hemmings DG, Hudson NK, Halliday D, O'Hara M, Baker PN, Davidge ST, Taggart MJ. Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod 2006; 74:88-94.
13. Hisamoto K, Bender JR. Vascular cell signaling by membrane estrogen receptors. Steroids 2005;70:382-387.
14. Hudson NK, O'Hara M, Lacey HA, Corcoran J, Hemmings DG, Wareing M, Baker PN, Taggart MJ. Modulation of human arterial tone during pregnancy: the effect of the bioactive metabolite Sphingosine-1-Phosphate. Biol Reprod 2007;77:45-52.
15. Liao WX, Magness RR, Chen D. Expression of estrogen receptors-α and -β in the pregnant ovine uterine artery endothelial cells in vivo and in vitro. Biol Reprod 2005;72:530-537.
16. Ma Y, Qiao X, Falone AE, Reslan OM, Sheppard SJ, Khalil RA. Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat. Cell Physiol Biochem 2010;26:457-470.
17. Miller VM, Duckles SP. Vascular actons of estrogens: functional implications. Pharmacol Rev 2008;60:210-241.
18. Montgomery S, Shaw L, Pantelides N, Taggart MJ, Austin C. The acute effects of oestrogen receptor subtype-specific agonists on vascular contractility. Br J Pharmacol 2003;139:1249-1253.
19. Myatt L. Control of vascular resistance in the human placenta. Placenta 1992; 13:329-341.
20. Norman M, Eriksson CG, Eneroth P. A comparison between the composition of maternal peripheral plasma and plasma collected from the retroplacental compartment at caesarean section. A study on protein and steroid hormones and binding proteins. Arch Gynecol Obstet. 1989;244:215-226.
21. O'Leary P, Boyne P, Flett P, Beilby J, James I. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem 1991;37:667-672.
22. Pastore MB, Jobe SO, Ramadoss J, Magness RR. Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow. Semin Reprod Med 2012;30:46-61.
23. Patker S, Farr TD, Cooper E, Dowell FJ, Carswell HVO. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neurosci Res 2011;71:78-84.
24. Revankar CB, Prossnitz ER. Atransmembrane intracellular estrogen receptor mediates rapid cell signalling. Science 2005;307:1625-1630.
25. Scott PA, Tremblay A, Brochu M, St-Louis J. Vasorelaxant action of 17-estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors. Am J Physiol 2007;293:H3713-H3719.
26. Shaw L, Taggart MJ, Austin C. Mechanisms of 17α-oestradiol-induced vasodilataion in isolated pressurised rat small arteries. Br J Pharmacol 2000;129:555-565.
27. Smith R, Klopper A, Hughes G, Wilson G. The compartmental distribution of oestrogens and pregnancy specific beta1 glycoprotein. Br J Obstet Gynaecol. 1979;86:119-124.
28. Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, Bisits AM, McElduffP, Giles WR, Smith DW. Patterns of plasma corticotrophinreleasing hormone, progesterone, estradiol and estriol change and the onset of human labor. J Clin Endocrinol Metab 2009;94:2066-2074.
29. Su EJ, Cheng YH, Chatterton RT, Lin ZH, Yin P, Reierstad S, Innes J, Bulun SE. Regulation of 17-β hydroxysteroid dehydrogenase type 2 in human placental endothelial cells. Biol Reprod 2007;77:517-525.
30. Su EJ, Lin ZH, Zeine R, Yin P, Reierstad S, Innes JE, Bulun SE. Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. Am J Obstet Gynecol 2009;200:427.e1-427.e8.
31. Su EJ, Ernst L, Abdallah N, Chatterton R, Xin H, Monsivais D, Coon J, Bulun SE. Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction. J Clin Endocrinol Metab 2011;96:E1558-E1567.
32. Sweeney M, Wareing M, Mills TA, Baker PN, Taggart MJ. Characterisation of tone oscillations in placental and myometrial arteries from normal pregnancies and those complicated by pre-eclampsia and growth restriction. Placenta 2008;29:356-365.
33. Wareing M, O'Hara M, Seghier F, Baker PN, Taggart MJ. The involvement of Rho-associated kinases in agonist-dependent contractions of human maternal and placental arteries at term gestation. Am J Obstet Gynecol 2005;193:815-824.
34. Wu Q, Chambliss K, Umetani M, Mineo C, ShaulPW. Non-nuclear estrogen receptor signalling in the endothelium. J Biol Chem 2011; 286:14737-14743.
35. You X, Yang R, Tang X, Gao L, Ni X. Corticotrophin-releasing hormone stimulates estrogen biosynthesis in cultured human placental trophoblasts. Biol Reprod 2006;74:1067-1072.